725 Followers on Owler

Fate develops programmed cellular immunotherapies for the treatment of metastatic cancer, traumatic injury and degenerative diseases...

Read more

Fate develops programmed cellular immunotherapies for the treatment of metastatic cancer, traumatic injury and degenerative diseases...

Read more
Fate Therapeutics President & CEO: Scott J. Wolchko

President & CEO

Scott J. Wolchko

CEO Approval Rating

79/100

Annual Revenue
$69M
Employees
500
Funding
366.3M
Acquisitions
1

Fate Therapeutics Competitors

1
2
3
4
5
6
7
8
9
10

Fate Therapeutics Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$69M

Fate Therapeutics's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 13.8B. Over the last four quarters, Fate Therapeutics's revenue has decreased by 12.2%. Specifically, in Q3 2022's revenue was $15M; in Q2 2022, it was $18.5M; in Q1 2022, it was $18.4M; in Q4 2021, Fate Therapeutics's revenue was $17.1M.

Fate Therapeutics News

Fate Therapeutics Press Releases

Fate Therapeutics Headquarters

3535 General Atomics Court Suite 200

San Diego, California92121

1-858-875-1800

Driving Directions »

Fate Therapeutics Summary

ABOUT

Overview

Fate develops programmed cellular immunotherapies for the treatment of metastatic cancer, traumatic injury and degenerative diseases. Fate Therapeutics was founded in 2007. Fate Therapeutics' headquarters is located in San Diego, California, USA 92121...

CEO

Fate Therapeutics's President & CEO, Scott J. Wolchko, currently has an approval rating of 79%. Fate Therapeutics's primary competitors are Kadmon, Juno Therapeutics & Chimerix.

Investments

Recent investment data cannot be found related to Fate Therapeutics

Frequently Asked Questions about Fate Therapeutics

  1. When was Fate Therapeutics founded?

    Fate Therapeutics was founded in 2007
  2. Who is Fate Therapeutics's CEO?

    Fate Therapeutics's CEO is Scott J. Wolchko
  3. How much revenue does Fate Therapeutics generate?

    Fate Therapeutics generates $69M in revenue
  4. How much funding does Fate Therapeutics have?

    Fate Therapeutics has historically raised $366.3M in funding
  1. Where is Fate Therapeutics's headquarters?

    Fate Therapeutics's headquarters is in San Diego California, USA
  2. How many employees does Fate Therapeutics have?

    Fate Therapeutics has 500 employees
  3. What sector does Fate Therapeutics operate in?

    Fate Therapeutics is in Biotechnology
  4. Who are Fate Therapeutics's competitors?

    Fate Therapeutics's top competitors are Kadmon, Juno Therapeutics, Chimerix

Trending Companies